Charles River Laboratories International, Inc. (CRL)
165.98
-15.26
(-8.42%)
USD |
NYSE |
Feb 11, 16:00
167.00
+1.02
(+0.61%)
After-Hours: 20:00
Charles River Laboratories International EPS Diluted (Quarterly) : 1.101 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Align Technology, Inc. | 1.892 |
| DaVita, Inc. | 3.29 |
| Johnson & Johnson | 2.098 |
| Thermo Fisher Scientific, Inc. | 5.21 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 55.56M |
| Revenue (Quarterly) | 1.005B |
| Total Expenses (Quarterly) | 950.43M |
| Enterprise Value | 10.64B |
| Gross Profit Margin (Quarterly) | 32.32% |
| Profit Margin (Quarterly) | 5.53% |
| Earnings Yield | -0.94% |
| Operating Earnings Yield | 5.77% |
| Normalized Earnings Yield | 2.054 |